Pharm Block 1 (PNS - Anticholinergic Agents) Flashcards

1
Q

Function of Anticholinergics Agents

A
  • block ACh’s interaction w/ either a muscarinic or nicotinic receptor
  • Effects are opposite of cholinergic stimulation (DUMBBELLS)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Three types of receptor antagonist (Anticholinergic Agents)

A

M - antimuscarinic
Nn - ganglionic blocker
Nm - neuromuscular (or skeletal) muscle blocking agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Eye

A

Dry eyes, cyloplegia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cardiovascular

A

Increase chronotrope/inotrope

Facial vasodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Respiratory

A

Bronchodilation

Decrease secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GI

A

Decrease

  • Secretions (Saliva & gastric, dry mouth)
  • peristalsis
  • sphincter constriction (constipation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Secretary glands

A

Decrease salivation, sweating, lacrimation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Major Therapeutic Uses of Anti-Muscarinic Agents

A
  • Reduce glandular and bronchiole secretions (atropine, glycopyrrolate)
  • Induce sedation (scopolamine)
  • Alleviate motion sickness (scopolamine)
  • Reduce vagal stimulation of the myocardium (atropine)
  • Reduce GI smooth muscle spasms
  • Parkinson’s Disease (adjunct therapy to decrease ACh lvs)
  • Treat bronchospasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindications & Warnings

Eye

A

Do NOT use in narrow angle glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Contraindications & Warnings

Cardiovascular

CNS

A

Cardiovascular: caution in angina (where increased HR exacerbates disease)

CNS: Minimize ‘anticholinergic load’ in px w/ Alzheimer’s Disease; coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contraindications & Warnings

Respiratory

GI

GU

A

Respiratory: do NOT use atropine for asthma (effects not constrained to lungs)

GI: do NOT sue for chronic diarrhea, gastroparesis, GI obstructions

GU: caution in px w/ Benign Prostatic Hyperplasia (BPH), GU obstructions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindications & Warnings

Secretary glands

Neuromuscular

A

Secretary Glands - may increase heart injuries due to decrease thermoregulatory sweating

Neuromuscular - avoid in px w/ myasthenia gravis (unless treating AChE inhibitor side effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is useful anticholinergic drug for Parkinson’s Disease?

A

Benztropine (Cogentin)

Trihexyphenidyl (Artane) - another one

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ganglionic Blockers are __________________ receptors blockers

A

Non-specific Nn (nicotinic neural)

No longer used therapeutically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neuromuscular Blocking Agents (NMBA)

A

it’s agents that

Block ACh at the Nm (nicotinic muscle) at the neuromuscular junction at the SKELETAL muscle

Order of paralysis (peripheral to central)
-face/eyes; fingers; limbs; neck; trunk muscles; intercostal muscles; diaphragm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does Curare induces neuromuscular paralysis?

A

Blocks the ability of ACh or similar agonist to activate Nm (nicotinic muscle) receptor at the neuromuscular junction at the skeletal muscle

17
Q

How is NMBA used for clinically?

A

For procedures that require muscle relaxation/paralysis

Ex)

  • facilitate endotracheal intubation
  • Paralyze mechanically ventilated px
  • relax skeletal muscles during surgery after general anesthesia has been induced

DO NOT effect consciousness or pain threshold

18
Q

NMBA’s are structural analogs of ACh and act as either in what?

A
  • Nondepolarizing (competitive inhibition)

- Depolarizing (Prolonged occupation and persistent binding)

19
Q

Ganglionic Blockers

A

Non-specific Nn (nicotinic neural) receptors blockers

NO longer used therapeutically